Lung Cancer: SWOG E5597 (Iowa Cancer Specialists)

SWOG E5597: Phase III Chemoprevention Trial of Selenium Supplementation in Persons with Resected Stage I Non-Small Cell Lung Cancer (NSCLC).

Objective

This research is being done because it is unknown if taking selenium can prevent the development of second lung cancers.

The purpose of this study is to find out if a high selenium yeast tablet can prevent new lung cancers in people with surgically removed non-small cell lung cancer.  The study will compare how the high selenium yeast affects patients with surgically removed lung cancer when compared to a placebo yeast.

Principal Investigator(s)
George Kovach

Clinical Trial Categories

  • Cancer
  • Lung (Non-Small Cell)
Sponsor(s)
SWOG
Contact
Kim Turner, R.N. at 563-421-1908
or turnerk@genesishealth.com

Location

  • Cancer Care Institute
    1351 West Central Park
    Pavilion 1, 1st Floor
    Davenport, IA 52804
    Main: 563-421-1900
    Alternate: 800-446-6088
    Fax: 563-421-1938

Contact Us

For more information about our research program and IRB, please contact:

Research Support Office
563-421-7955

Email